|
|
Poster Abstract Session:
197. Influenza Vaccines
Saturday, October 20, 2012: 12:30 PM-2:00 PM
Room: SDCC Poster Hall F-H
Topical Category: I. Adult and Pediatric Vaccines and P. Pediatric and Perinatal Infections
Tracks: Adult ID, Pediatric ID
Presentations:
|
Breast Milk Antibody and Neutralization Activity at One Year Postpartum after Antenatal Influenza Immunization
Mark Steinhoff, MD, FIDSA
;
Elizabeth P. Schlaudecker, M.D., M.P.H.
;
Saad B. Omer, MBBS, MPH, PhD
;
Monica McNeal, MS
;
Eliza Roy, DCH
;
Shams E. Arifeen, MBBS, DrPH
;
Caitlin Dodd, M.S.
;
Rubhana Raqib, PhD
;
Robert Breiman, MD
;
Khalequ Zaman, MBBS, PhD
|
|
Immunogenicity and Safety Profile of an AS03-Adjuvanted H5N1 Vaccine in Children 6 Months to <18 Years of Age: a Randomized Multi-center Trial
Pope Kosalaraksa, MD.
;
Robert Jeanfreau, MD
;
Louise Frenette, MD
;
Mamadou Dramé, MSc
;
Miguel Madariaga, MD, MSc
;
Olivier Godeaux, MD
;
Patricia Izurieta, MD, Ph.D
;
David Vaughn, MD, MPH
|
|
The Safety and Immunogenicity of High Dose Trivalent Influenza Vaccine (TIV) Compared to Standard Dose TIV in Pediatric Solid Organ Transplant (SOT) Patients
Sarah Rich, MD
;
Marian Michaels, MD, MPH
;
Jonathan A. McCullers, MD
;
Wenli Wang, MS
;
Steve Ampah, MS
;
Alice O'Shea, RN
;
Michael Green, MD, MPH
;
Natasha Halasa, MD MPH
|
|
Trivalent Inactivated Influenza Vaccine (TIV) and Live Attenuated Influenza Vaccine (LAIV) Induce Different B cell Responses in Blood of Immunized Children
Raquel Giacomelli Cao, MD
;
Santiago M.C. López, MD
;
Emilio Flaño, PhD
;
Gerlinde Obermoser, MD
;
Sara Mertz, BS
;
Shelli Farley
;
Paulla Davies
;
Adolfo Garcia-Sastre, PhD
;
Randy Albrecht, PhD
;
Asuncion Mejias, MD, PhD
;
Octavio Ramilo, MD
|
|
Immunogenicity and Safety of FluzoneHD, a High-Dose Influenza Vaccine, versus Fluzone, a Standard-Dose Influenza Vaccine in Children with Cancer or HIV: a Randomized, Open-label, Clinical Trial
Hana Hakim, MD, MS
;
Kim J. Allison, BSN
;
Lee-Ann Van De Velde, BBiomedSc(Hons)
;
Amy Iverson, BS
;
Patricia M. Flynn, MD, MS
;
Jonathan A. McCullers, MD
|
|
School-Located Influenza Vaccinations Decrease Laboratory-Confirmed Influenza Rates and Improves School Attendance
Pia Pannaraj, MD, MPH
;
Alvin Nelson El Amin, MD, MPH
;
Hailin Wang, MPH
;
Chrysanthy Ha, MPH
;
Hector Rivas
;
Michael Smit, MD, MSPH
;
Grace Aldrovandi, MD
;
Laurene Mascola, MD, MPH
|
|
Evaluation of the Neuraminidase-Inhibiting Antibody Response to Inactivated Influenza Vaccine by Enzyme-Linked Lectin Assay
Maryrose Laguio, MD
;
Mark Thompson, Ph. D
;
Manjusha Gaglani, MBBS
;
Allison Naleway, PhD
;
Sarah Spencer, Ph.D
;
Sarah Ball, MPH, ScD
;
Steven Baker, B.S., M.S.
;
Luis Martinez-Sobrido, Ph.D.
;
David Shay, MD, MPH
;
John J. Treanor, MD
|
|
Seasonal and Pandemic Vaccine Effectiveness in the Prevention of Influenza-related Hospitalization in Canadian Adults
Shelly McNeil, MD
;
Allison McGeer, MD, FSHEA
;
Karen Green, MSc
;
Ardith Ambrose, RN
;
Jennie Johnstone, MD
;
Todd Hatchette, MD
;
Jason LeBlanc, PhD
;
Duncan Webster, MD
;
Mark Loeb, MD
;
Anne McCarthy, MD, MSc
;
Guy Boivin, MD
;
Sylvie Trottier, MD
;
Christina Wang
;
Melissa Andrew, MD, PhD
;
Louis Valiquette, MD
;
Grant Stiver, MD
|
|
Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate versus Two Trivalent Influenza Vaccines: a Randomized Controlled Trial in Adults
Juan Carlos Tinoco, MD
;
Noris Pavia-Ruz, MD, MSc
;
Aurelio Cruz-Valdez, PhD
;
Carlos Aranza Doniz, MD
;
Vijayalakshmi Chandrasekaran, MSc
;
Walthère Dewé, MSc
;
Aixue Liu, MD, PhD
;
Bruce L. Innis, MD
;
Varsha K. Jain, MD, MPH
|
|
Evaluation of a Standardized Measure for Reporting Healthcare Personnel Influenza Vaccination Data, 2010-2011
Megan C. Lindley, MPH
;
Faruque Ahmed, PhD
;
Suchita Lorick, DO
;
Tara MacCannell, PhD
;
Anita Geevarughese, MD, MPH
;
Robert Harrison, MD, MPH
;
David Nace, MD, MPH
;
Carmela Smith, MS
|
CME Credits:
Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.
|